Metabolic Peptides
Metabolic peptides target pathways involved in glucose homeostasis, lipid metabolism, satiety signaling, and energy expenditure. Research in this category explores how these compounds interact with incretin receptors, growth hormone axes, and mitochondrial function.
Semaglutide
GLP-1 receptor agonist. Research into satiety signaling, insulin secretion, and metabolic pathways.
From €8110mg lyophilised
Tirzepatide
The Dual Agonist
Dual GIP/GLP-1 receptor agonist. Superior metabolic pathway regulation research compound.
From €16140mg lyophilised
Tesamorelin
The GH Releaser
GHRH analogue. FDA-approved backbone compound for growth hormone secretion research.
From €8610mg lyophilised
Retatrutide
The Triple
Triple GIP/GLP-1/Glucagon receptor agonist. Next-generation metabolic compound with three synergistic pathways.
From €18910mg lyophilised
AOD-9604
The Sculptor
Modified fragment (176–191) of human growth hormone. Studied for its role in lipid metabolism without affecting IGF-1 or insulin levels.
From €525mg lyophilised
5-Amino-1MQ
The Furnace
Selective NNMT inhibitor. Studied for activation of cellular energy expenditure and reduction of lipid accumulation in adipocyte models.
From €5550mg capsules (30ct)
CagriSema
The Catalyst
Co-formulation of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist). Studied for dual-pathway satiety signaling and metabolic regulation surpassing single-agent approaches.
From €1455mg lyophilised
BAM15
The Uncoupler
Selective mitochondrial protonophore. Studied for uncoupling oxidative phosphorylation to increase energy expenditure without raising core body temperature.
From €4850mg powder